Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Perspective Therapeutics (CATX) EBT Margin (2016 - 2023)

Perspective Therapeutics' EBT Margin history spans 14 years, with the latest figure at 158.57% for Q4 2023.

  • On a quarterly basis, EBT Margin changed N/A to 158.57% in Q4 2023 year-over-year; TTM through Dec 2023 was 6542.58%, a N/A change, with the full-year FY2023 number at 2796.79%, changed N/A from a year prior.
  • EBT Margin hit 158.57% in Q4 2023 for Perspective Therapeutics, up from 473.96% in the prior quarter.
  • Over the last five years, EBT Margin for CATX hit a ceiling of 158.57% in Q4 2023 and a floor of 740.4% in Q2 2023.
  • Historically, EBT Margin has averaged 129.93% across 5 years, with a median of 52.13% in 2020.
  • Biggest five-year swings in EBT Margin: soared 10180bps in 2021 and later plummeted -65745bps in 2023.
  • Tracing CATX's EBT Margin over 5 years: stood at 40.66% in 2019, then increased by 10bps to 36.8% in 2020, then plummeted by -55bps to 56.96% in 2021, then tumbled by -316bps to 236.92% in 2022, then soared by 167bps to 158.57% in 2023.
  • Business Quant data shows EBT Margin for CATX at 158.57% in Q4 2023, 473.96% in Q3 2023, and 740.4% in Q2 2023.